Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Users Online: 181 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies
Katja Akgün,Ute Essner,Cordula Seydel,Tjalf Ziemssen
Journal of Central Nervous System Disease.2019;11()117957351983199
2Evaluating DREAMS HIV prevention interventions targeting adolescent girls and young women in high HIV prevalence districts in South Africa: protocol for a cross-sectional study
Gavin George,Cherie Cawood,Adrian Puren,David Khanyile,Annette Gerritsen,Kaymarlin Govender,Sean Beckett,Mary Glenshaw,Karidia Diallo,Kassahun Ayalew,Andrew Gibbs,Tarylee Reddy,Lorna Madurai,Tendesayi Kufa-Chakezha,Ayesha B. M. Kharsany
BMC Women's Health.2020;20(1)117957351983199
3The use of real-world evidence for evaluating anti–vascular endothelial growth factor treatment of neovascular age-related macular degeneration
James Talks,Vincent Daien,Robert P. Finger,Bora Eldem,Taiji Sakamoto,José Augusto Cardillo,Paul Mitchell,Tien Yin Wong,Jean-François Korobelnik
Survey of Ophthalmology.2019;64(5)707
4PHEDRA: using real-world data to analyze treatment patterns and ibrutinib effectiveness in hematological malignancies
Jamie Garside,Nollaig Healy,Hervé Besson,Ruben Hermans,Finlay MacDougall,Damien Lestelle,Joris Diels,Wafae Iraqi
Journal of Comparative Effectiveness Research.2018;7(1)29
5Overall Survival of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma Treated with Nimotuzumab in the Real World
Yaimarelis Saumell,Lizet Sanchez,Sandra González,Ramón Ortiz,Edadny Medina,Yaima Galán,Agustin Lage
Advances in Therapy.2017;34(12)2638
6The positive impacts of Real-World Data on the challenges facing the evolution of biopharma
John Wise,Angeli Möller,David Christie,Dipak Kalra,Elia Brodsky,Evelina Georgieva,Greg Jones,Ian Smith,Lars Greiffenberg,Marie McCarthy,Michael Arend,Olivier Luttringer,Sebastian Kloss,Steve Arlington
Drug Discovery Today.2018;23(4)788
7Real-World Treatment Patterns and Outcomes in Patients Receiving Second-Line Therapy for Advanced/Metastatic Esophageal Squamous Cell Carcinoma
Pranav Abraham,Joe Gricar,Ying Zhang,Veena Shankaran
Advances in Therapy.2020;37(7)3392
8Population-Based Registry Linkages to Improve Validity of Electronic Health Record–Based Cancer Research
Caroline A. Thompson,Anqi Jin,Harold S. Luft,Daphne Y. Lichtensztajn,Laura Allen,Su-Ying Liang,Benjamin T. Schumacher,Scarlett Lin Gomez
Cancer Epidemiology Biomarkers & Prevention.2020;29(4)796
9Dual Therapy Appears Superior to Monotherapy for Low-Income Individuals With Newly Diagnosed Type 2 Diabetes
Elizabeth M. Vaughan,Craig A. Johnston,David J. Hyman,Daphne C. Hernandez,Vagish Hemmige,John P. Foreyt
Journal of Primary Care & Community Health.2017;8(4)305
10An Observational Study Assessing Changes in Health and Functional Status in Patients with Chronic Obstructive Pulmonary Disease (COPD) During Therapy with Spiolto® Respimat® in Everyday Clinical Practice: The Greek ELLACTO Study
Epaminondas Kosmas,Iraklis Titopoulos,Georgios Patentalakis,Nikos Nikas
Pulmonary Therapy.2021;8(4)305
11Do current approaches to assessing therapy related adverse events align with the needs of long-term cancer patients and survivors?
Syril D. Pettit,Rebecca Kirch
12Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data
Maria Lindh,Jonas Banefelt,Kathleen M Fox,Sara Hallberg,Ming-Hui Tai,Mats Eriksson,Guillermo Villa,Maria K Svensson,Yi Qian
European Heart Journal - Quality of Care and Clinical Outcomes.2019;5(3)225
13Awareness, Knowledge, and Utility of RCT Data vs RWE: Results From a Survey of US Cardiologists: Real-world Evidence in Clinical Decision Making
Todd C Villines,Mark J Cziraky,Alpesh N Amin
Clinical Medicine Insights: Cardiology.2020;14(3)117954682095341
14Measuring atopic eczema symptoms in clinical practice: The first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiative
Yael A. Leshem,Joanne R. Chalmers,Christian Apfelbacher,Masutaka Furue,Louise A.A. Gerbens,Cecilia A.C. Prinsen,Jochen Schmitt,Phyllis I. Spuls,Kim S. Thomas,Hywel C. Williams,Eric L. Simpson
Journal of the American Academy of Dermatology.2020;82(5)1181
15Twelve-week ribavirin-free direct-acting antivirals for treatment-experienced Chinese with HCV genotype 1b infection including cirrhotic patients
Dong Ji,Guo-Feng Chen,Cheng Wang,Yu-Dong Wang,Qing Shao,Bing Li,Jun Zhao,Shao-Li You,Jin-Hua Hu,Jia-Liang Liu,Xiao-Xia Niu,Jing Chen,Lei Lu,Vanessa Wu,George Lau
Hepatology International.2016;10(5)789
16Inventory of real world data sources in Parkinson’s disease
Audrey Tanguy,Linus Jönsson,Lianna Ishihara
BMC Neurology.2017;17(1)789
17A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real-World” vs Clinical Trials
José Miguel Rivera-Caravaca,María Asunción Esteve-Pastor,Francisco Marín,Mariano Valdés,Vicente Vicente,Vanessa Roldán,Gregory Y.H. Lip
Mayo Clinic Proceedings.2018;93(8)1065
18Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion
Manuel Casselholm de Salles,David Epstein
Graefe's Archive for Clinical and Experimental Ophthalmology.2021;93(8)1065
19Cost-effectiveness of direct oral anticoagulants versus vitamin K antagonist in atrial fibrillation
Zojaina Hernández Rojas,Maria Rosa Dalmau Llorca,Carina Aguilar Martín,Alessandra Queiroga Gonçalves,Marc Casajuana,José Fernández-Sáez,Dolores Rodríguez Cumplido,Emma Forcadell Drago,Nočlia Carrasco-Querol,Josep Maria Pepió Vilaubí,Josep M. Alegret
20Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: A retrospective database study in France
Philippe Devillier,Mathieu Molimard,Xavier Ansolabehere,Isabelle Bardoulat,Nicolas Coulombel,Frédérique Maurel,Philippe Le Jeunne,Pascal Demoly
21A Prospective, Observational, Cohort Study to Assess the Efficacy and Safety of Prolonged-Release Fampridine in Cognition, Fatigue, Depression, and Quality of Life in Multiple Sclerosis Patients: The FAMILY Study
Dimos D. Mitsikostas,Triantafyllos Doskas,Stylianos Gkatzonis,Nikolaos Fakas,Maria Maltezou,Dimitrios Papadopoulos,Rania Gourgioti,Panayiotis Mitsias
Advances in Therapy.2021;38(3)1536
22Randomized clinical trials and real life studies: Comparison of baseline characteristics of patients in oral target therapies for renal cell carcinoma
Ruggero Lasala,Fiorenzo Santoleri,Alessia Romagnoli,Felice Musicco,Paolo Abrate,Alberto Costantini
Journal of Oncology Pharmacy Practice.2021;38(3)107815522110055
23Improving Population Pharmacokinetics Through the Use of Genetic Algorithms
Mikhail Morozov,Ezequiel Nuske,Héctor Alejandro Serra
Journal of Pharmaceutical Innovation.2021;16(1)152
24Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study
Mijin Kim,Tae Hyuk Kim,Dong Yeob Shin,Dong Jun Lim,Eui Young Kim,Won Bae Kim,Jae Hoon Chung,Young Kee Shong,Bo Hyun Kim,Won Gu Kim
25Real-world experience with use of Antihemophilic Factor (Recombinant), PEGylated for prophylaxis in severe haemophilia A
A. L. Dunn,S. P. Ahuja,E. S. Mullins
26Real-world evidence of subcutaneous allergoid immunotherapy in house dust mite-induced allergic rhinitis and asthma
Marek Jutel,Bernd Brüggenjürgen,Hartmut Richter,Christian Vogelberg
27Trial designs using real-world data: The changing landscape of the regulatory approval process
Elodie Baumfeld Andre,Robert Reynolds,Patrick Caubel,Laurent Azoulay,Nancy A. Dreyer
Pharmacoepidemiology and Drug Safety.2020;29(10)1201
28Effectiveness of comprehensive traditional Korean Medicine treatment on quality of life, anorexia and cachexia of cancer patients: Retrospective chart review
Wonju Han,Eunji Lee,Gajin Han,Sang-hoon Yoon,Gajin Han,Jungtae Leem
Journal of Korean Medicine.2019;40(2)119
29Olaparib as maintenance therapy in patients with BRCA 1–2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome
Sabrina Chiara Cecere,Gaia Giannone,Vanda Salutari,Laura Arenare,Domenica Lorusso,Graziana Ronzino,Rossella Lauria,Gennaro Cormio,Claudia Carella,Paolo Scollo,Viola Ghizzoni,Francesco Raspagliesi,Marilena Di Napoli,Enrica Mazzoni,Claudia Marchetti,Alice Bergamini,Michele Orditura,Giorgio Valabrega,Giovanni Scambia,Giuseppa Maltese,Elisabetta De Matteis,Cinzia Cardalesi,Vera Loizzi,Serena Boccia,Emanuele Naglieri,Giuseppa Scandurra,Sandro Pignata
Gynecologic Oncology.2020;156(1)38
30Effectiveness and Tolerability of Vildagliptin and the Single Pill Combination of Vildagliptin and Metformin in “Real-World” Management of Type 2 Diabetes Mellitus: The G-FORCE Study
Luc Van Gaal,Michel P. Hermans,Evis Daci,Kris Denhaerynck,Lut De Meester,Karen MacDonald,Ivo Abraham,Stefaan Vancayzeele,Michael Maris
Diabetes Therapy.2019;10(3)965
31Copper IUD continuation, unwanted effects and cost consequences at 1 year in users aged under 30 – a secondary analysis of the EURAS-IUD study
Hannat Akintomide,Nataliya Brima,Diana J. Mansour,Jill Shawe
The European Journal of Contraception & Reproductive Health Care.2021;26(3)175
32Data Integration to Improve Real-world Health Outcomes Research for Non–Small Cell Lung Cancer in the United States: Descriptive and Qualitative Exploration
Michael Grabner,Cliff Molife,Liya Wang,Katherine B Winfree,Zhanglin Lin Cui,Gebra Cuyun Carter,Lisa M Hess
JMIR Cancer.2021;7(2)e23161
33Il trattamento con farmaci intravitreali anti-VEGF in pazienti naďve in Italia
M Albrecht,M Nica,D Colombo,C Ferri,P Tadini,U Introini,F Bandello
Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish.2018;2018(2)228424031879390
34Ethical Issues in Democratizing Digital Phenotypes and Machine Learning in the Next Generation of Digital Health Technologies
Maurice D. Mulvenna,Raymond Bond,Jack Delaney,Fatema Mustansir Dawoodbhoy,Jennifer Boger,Courtney Potts,Robin Turkington
Philosophy & Technology.2021;2018(2)228424031879390
35Moving Auto-Correlation Window Approach for Heart Rate Estimation in Ballistocardiography Extracted by Mattress-Integrated Accelerometers
Marco Laurino,Danilo Menicucci,Angelo Gemignani,Nicola Carbonaro,Alessandro Tognetti
36Sacubitril/Valsartan in Daily Clinical Practice
Lourdes Vicent,Alberto Esteban-Fernández,Manuel Gómez-Bueno,Javier De-Juan,Pablo Díez-Villanueva,Ángel Manuel Iniesta,Ana Ayesta,Hugo González-Saldívar,Antonio Rojas-González,Ramón Bover-Freire,Diego Iglesias,Marcos García-Aguado,Jesús A. Perea-Egido,Manuel Martínez-Sellés
Journal of Cardiovascular Pharmacology.2019;73(2)118
37Real-world cardiovascular disease burden in patients with atherosclerotic cardiovascular disease: a comprehensive systematic literature review
Dasha Cherepanov,Tanya G.K. Bentley,Wendy Hsiao,Pin Xiang,Frank O’Neill,Yi Qian,Nicole Yurgin,David Beenhouwer
Current Medical Research and Opinion.2018;34(3)459
38Cost-Effectiveness of Ibrutinib Compared With Obinutuzumab With Chlorambucil in Untreated Chronic Lymphocytic Leukemia Patients With Comorbidities in the United Kingdom
Richa Sinha,William Ken Redekop
Clinical Lymphoma Myeloma and Leukemia.2018;18(2)e131
39The Genotype forDPYDRisk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice
Giuseppe Toffoli,Federico Innocenti,Jerry Polesel,Elena De Mattia,Franca Sartor,Chiara Dalle Fratte,Fabrizio Ecca,Eva Dreussi,Elisa Palazzari,Michela Guardascione,Angela Buonadonna,Luisa Foltran,Marica Garziera,Alessia Bignucolo,Stefania Nobili,Enrico Mini,Adolfo Favaretto,Massimiliano Berretta,Mario D'Andrea,Antonino De Paoli,Rossana Roncato,Erika Cecchin
Clinical Pharmacology & Therapeutics.2019;105(4)994
40Responder rates to fampridine differ between clinical subgroups of MS patients and patient reported outcome influences treatment decision making
C.E.P. van Munster,L. Kaya,K.H. Lam,N.F. Kalkers,J. Killestein,B.M.J. Uitdehaag
Multiple Sclerosis and Related Disorders.2020;38(4)101489
41Textile-Based Pressure Sensing Matrix for In-Bed Monitoring of Subject Sleeping Posture and Breathing Activity
Nicola Carbonaro,Marco Laurino,Lucia Arcarisi,Danilo Menicucci,Angelo Gemignani,Alessandro Tognetti
Applied Sciences.2021;11(6)2552
42Evaluating beneficial drug effects in a non-interventional setting: a review of effectiveness studies based on Swedish Prescribed Drug Register data
Susanna M. Wallerstedt,Mikael Hoffmann
British Journal of Clinical Pharmacology.2017;83(6)1309
43Cardiovascular Event Rates After Myocardial Infarction or Ischaemic Stroke in Patients with Additional Risk Factors: A Retrospective Population-Based Cohort Study
Emil Hagström,Francesc Sorio Vilela,Maria K. Svensson,Sara Hallberg,Emma Söreskog,Guillermo Villa
Advances in Therapy.2021;83(6)1309
44Proceed with Caution When Using Real World Data and Real World Evidence
Hun-Sung Kim,Ju Han Kim
Journal of Korean Medical Science.2019;34(4)1309
45Bleeding Events in Patients 75 Years of Age and Older Under Long-term Anticoagulant Therapy: A Real-life Study
Alberto Conti,Noemi Renzi,Stefania Catarzi,Mariuccia Mazzucchelli,Antonella Covelli,Alessandro Pampana,Giada Bongini,Giacomo Bini,Marco Leorin,Lorenzo Ghiadoni
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine.2020;19(3)131
46Utilisation of real-world data from heart failure registries in OECD countries - A systematic review
Xiaoyang Du,Adina Khamitova,Mattias Kyhlstedt,Sun Sun,Mathilde Sengoelge
IJC Heart & Vasculature.2018;19(3)90
47Initiation and titration of sacubitril/valsartan in different types of centers
Antonio Rojas-González,Ana Ayesta,Lourdes Vicent,Alberto Esteban-Fernández,Manuel Gómez-Bueno,Javier De-Juan,Pablo Díez-Villanueva,Ángel Iniesta,Hugo González-Saldívar,Ramón Bover-Freire,Diego Iglesias,Marcos García-Aguado,Jesús Perea-Egido,Manuel Martínez-Sellés
REC: CardioClinics.2021;56(2)92
48A Comparison of Real-World Treatment Patterns and Clinical Outcomes in Patients Receiving First-Line Therapy for Unresectable Advanced Gastric or Gastroesophageal Junction Cancer Versus Esophageal Adenocarcinomas
Veena Shankaran,Hong Xiao,David Bertwistle,Ying Zhang,Min You,Pranav Abraham,Ian Chau
Advances in Therapy.2021;38(1)707
49Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis
Philippe Devillier,Ulrich Wahn,Stefan Zielen,Joachim Heinrich
Expert Review of Clinical Immunology.2017;13(12)1199
50Fostering the exchange of real world data across different countries to answer primary care research questions: an UNLOCK study from the IPCRG
Liza Cragg,Siân Williams,Thys van der Molen,Mike Thomas,Jaime Correia de Sousa,Niels H. Chavannes
npj Primary Care Respiratory Medicine.2018;28(1)1199
51Clinical and Patient-Reported Outcomes of Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C Among Patients on Opioid Agonist Treatment: A Real-world Prospective Cohort Study
Bernd Schulte,Christiane S Schmidt,Jakob Manthey,Lisa Strada,Stefan Christensen,Konrad Cimander,Herbert Görne,Pavel Khaykin,Norbert Scherbaum,Stefan Walcher,Stefan Mauss,Ingo Schäfer,Uwe Verthein,Jürgen Rehm,Jens Reimer
Open Forum Infectious Diseases.2020;7(8)1199

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal